跟讀練習: Breast Pathology Cases 3 and 4 - 通過影片學習英語口語

選擇練習模式

每種模式都會開啟全屏練習室。

160 句

如果句子過短或過長，請點選 Edit 進行調整。

This is breast pathology cases 3 and 4.

This is a biopsy that was done for calcifications and from low magnification you can see we have multiple duct profiles that are being filled in by epithelial cells.

So let's take a closer look.

Closer inspection of this single duct shows that it's filled in by a population of atypical cells that are forming this cribriform architectural pattern.

Notice that these punched out spaces are relatively round and uniform and there is polarization of cells around the punched out spaces.

Here is a closer view of these cribriform structures.

Again, most of them are nice and round and uniform.

And lining these cribriform structures, you have a population of atypical cells with pleomorphic nuclei, hyperchromasia, pseudoinclusions, which is not a typical finding here.

But in general, lack of big prominent nucleoli.

There may be a few nucleoli in here, but for the most part, I would say it's relatively low to intermediate in its nuclear grade.

Let's step out one magnification and refer back to our previous case where we looked at a case of atypical

ductal hyperplasia and we said one of the key characteristics was basically partial duct involvement or involvement of a single duct profile.

Here we have, for the most part, most of these are complete duct involvement, meaning there's no residual normal ductal epithelium, no areas that look like usual ductal hyperplasia.

So we have a full duct profile here and we have several others that are fully involved as well.

So we have full duct involvement and multiple profiles that are involved.

So this meets criteria for ductal carcinoma in situ.

Then it comes down to really two things when you're dealing with ductal carcinoma in situ.

What is the nuclear grade and is there comedonecrosis?

There are various different subtypes of DCIS, and for the most part they're not important clinically.

What does matter is nuclear grade and presence or absence of comedonecrosis.

What you'll find with many cases of DCIS is you really have a spectrum of nuclear grade.

And in this particular case, I would say that most of the cells that we're seeing are relatively small and uniform.

We're not seeing a lot of nuclear membrane irregularities.

We're not seeing macronucleoli.

So I would call these low grade.

And then we have cells like this.

They're larger, they're a little more pleomorphic.

We have evacuated chromatin pattern and a lot of nuclear folds or nuclear membrane irregularities.

So in this particular case, I would call it ductal carcinoma in situ, low to intermediate nuclear grade.

And although I haven't shown the whole case, there was no comedonecrosis.

This is case four, which is also a biopsy done for calcifications.

And in this single focus, you can see that we have one, two, three, and maybe even four duct profiles involved by an intraductal proliferation.

Now it's clear from low power that for most people who are experienced what this is going to be, but let's walk through this systematically.

So we have an intraductal proliferation.

Is this invasive?

No.

Why?

It has rounded profiles, number one, and there's no desmoplasia.

Now there's a slight stromal reaction here, but it doesn't have an infiltrative pattern to it, and it's not pushing into the fat.

So we're dealing with an intraductal proliferation.

We had mentioned in our previous discussion that the general differential is between usual ductal hyperplasia, atypical ductal hyperplasia, and ductal carcinoma in situ.

So let's look closer at one of these duct profiles.

Here is a closer view showing several things.

First, there is a full duct involvement by this intraductal proliferation.

There is no residual normal duct epithelium and no areas that look like usual ductal hyperplasia, but let's explain why it's not usual ductal hyperplasia.

Remember that when we talked about usual ductal hyperplasia, we said that there was an intraductal proliferation that filled the lumen, and it was generally a disorderly arrangement as it moved into the lumen.

And in most cases of usual ductal hyperplasia, the cells get smaller as they move into the lumen.

Now you may say these cells look small, but this whole region here is all necrosis.

So let's ignore this for a moment and look at the viable cells.

So what do you see?

You see relative uniformity in the sense that they all look like a similar cell population, although there is pleomorphism.

Some are larger, some are smaller.

What do you see in terms of nuclear morphology?

Well, number one, the nuclei are enlarged.

The chromatin pattern is somewhat even although we do have some small nucleolite that are beginning to form.

There's abundant cytoplasm and there are conspicuous cell membranes.

There's even a mitotic figure here.

As they move into the lumen they become necrotic, so we have central necrosis.

And notice that the necrosis pushes on the epithelium and compresses it.

In other words it causes architectural change to the surrounding epithelium.

This is referred to as comedonecrosis.

So we have here ductal carcinoma in situ based on full duct involvement, based on multiple duct profiles, and also because we have a higher nuclear grade.

Let's look closer at some of these nuclei.

Here is a high magnification view of these cells.

So first of all, they are ductal epithelial in origin.

And you can tell that because you can make out the cell membranes and the cohesive nature of the epithelial cells.

When you're dealing with lobular neoplasia, either LCIS, which is lobular carcinoma in situ, or atypical lobular hyperplasia, one of its key characteristics is the lack of cellular cohesion, so it becomes more discohesive.

Here we have a cohesive process where you can make out cell membranes, abundant cytoplasm, And again, we have pleomorphic nuclei, some binucleation.

You can make out some notching and nuclear membrane irregularities.

The diagnosis for case 3 is ductal carcinoma in situ, low to intermediate grade.

The diagnosis for case 4 is ductal carcinoma in situ, high grade.

And you would also mention the presence of comedonecrosis.

Ductal carcinoma in situ is a neoplastic proliferation of ductal epithelial cells that is confined to the ductal or lobular system,

basically referring to the fact that it does not extend beyond the basement membranes and it retains an intact myoepithelial cell layer.

So if you were to use myoepithelial stains such as smooth muscle myosin, calponin, and you would see that these lesions would have an intact myopithelial cell layer.

These most commonly present as mammographic calcifications, and they have many different growth patterns that are described, many different subtypes that are described,

but as I had mentioned, the most important factors are nuclear grade, be it low grade, intermediate grade, or high grade,

and the presence or absence of comedonecrosis, which is a central type of necrosis that has architectural changes to the surrounding epithelium.

So it has a sort of compressive effect on the surrounding epithelium.

So we're going to go through a couple examples of DCIS and you need to name the type of DCIS.

This type would be cribriform because of its prominent cribriform architecture.

The next type would be solid.

Here it lacks the cribriform architecture although you can see a little bit over here, The solid type is essentially where you get a uniform proliferation of atypical cells within the lumen that lack any sort of cribriform architecture.

Here's an example of DCIS.

It's filling in the lumen, but even from low magnification, you can make out these fibrovascular cores.

It has a rounded border, so it's non-infiltrative.

There's no desmoplasia.

So this is DCIS of the papillary type.

What about this one?

Notice here we have atypical or malignant appearing epithelial cells filling in partially into the lumen, making these papillary-like structures, but they lack fibrovascular cores.

This is micropapillary DCIS.

What about this pattern?

Here we have central necrosis that's expanding and compressing the surrounding epithelium.

So this would be comedotype DCIS.

So with ductal carcinoma in situ, what to document?

You need to document nuclear grade, low, intermediate, or high.

And it's not uncommon to see a spectrum, so you can report low to intermediate or intermediate to high.

And then you need to document the presence and type of necrosis.

The most important type is that pattern that we saw, which is central with expansile features, which is called comedonecrosis.

100

But you can also see punctate central necrosis that has no impact on the surrounding epithelium.

101

And then you can report architectural patterns, although they are of less clinical significance.

102

Here's an example of low-grade DCIS.

103

You can see the relative uniformity of the cells that are filling in the lumen.

104

They're not all that different than the ADH type nuclei that we had seen in the previous case except that it's full duct involvement and it's multiple ducts involved.

105

Notice that the nuclei are round, they're monotonous, and the nucleoli are inconspicuous.

106

Now it's hard to tell from this power, but in general you're not going to see prominent macronucleoli.

107

You may find mitotic activity, but generally it's not going to be as frequent as you'll see in the higher grades of DCIS.

108

Here's another example of ductal carcinoma in situ of the micropapillary type, low nuclear grade.

109

Here's an example of high grade DCIS.

110

This would be of the comedotype, so we have central necrosis that has an expansile appearance to it.

111

We have markedly atypical nuclei, prominent nuclei, mitotic activity.

112

This is high-grade DCIS.

113

Here's another example of high-grade DCIS.

114

This is one that is known as the clinging type, where you have essentially a single layer of malignant-appearing cells.

115

In this particular case, we have some central necrosis.

116

Here's an example of intermediate grade DCIS.

117

We have mild to moderate nuclear pleomorphism, and the nucleoli are variably conspicuous.

118

Question, which of the following statements regarding low grade DCIS is false?

119

So let's just go through each one and say true or false.

120

Low-grade DCIS typically shows strong and diffuse expression of ER and PR.

121

True.

122

Low-grade DCIS typically has a low proliferative rate by KI-67.

123

True.

124

Low-grade DCIS typically lacks expression of cytokeratin 5-6.

125

True.

126

So you can exclude this one.

127

They do not typically have HER2 overexpression.

128

Now you should not, there's two things I would note here.

129

On all cases of DCIS, you're going to order estrogen and progesterone receptor.

130

There's no need to order a KI-67 and there's no reason to order HER2.

131

But you will find if you do have cases of invasive ductal carcinoma in which HER2 is ordered that it's not uncommon for it to be overexpressed in cases of high-grade DCIS, but generally it's going to be negative in cases of low-grade DCIS.

132

Question, what immunohistochemical stain is the most clinically relevant for DCIS?

133

Answer, estrogen receptor.

134

So tamoxifen significantly reduces the risk of local recurrence in patients with ER-positive DCIS.

135

So ER is important.

136

Question.

137

Which of the following features is associated with local recurrence following breast conserving treatment for DCIS?

138

You may pick more than one.

139

Answer.

140

All of these features.

141

So high nuclear grade, presence of comedor necrosis, a young patient age, less than 45 years, a large lesional size, and a positive margin are all associated with increased risk of local recurrence.

142

The most important among these is positive margin.

143

With respect to recurrence, around half of cases are DCIS and the other half are invasive carcinoma.

144

You make the diagnosis of low-grade DCIS on a needle core biopsy.

145

To what degree is this patient's risk elevated for developing invasive carcinoma?

146

Eight to tenfold.

147

What breast site is at risk?

148

Is it ipsilateral, contralateral, or bilateral?

149

Ipsilateral.

150

So to summarize, low-grade DCIS, 8 to 10-fold increased risk of developing invasive carcinoma, with the greatest risk being the ipsilateral breast.

151

So to summarize, we had said in the previous case that atypical ductal hyperplasia is associated with a 3-5 fold increased risk of developing invasive carcinoma.

152

With low-grade DCIS, it's elevated beyond that, it's 8-10 fold.

153

We mentioned that with atypical ductal hyperplasia, the risk was bilateral.

154

With low-grade DCIS, it puts greater risk on the side of the DCIS.

155

The treatment for atypical ductal hyperplasia is watching the patient, number one, and the and potentially tamoxifen to help reduce the risk.

156

For patients with low-grade DCIS on a needle core biopsy, the DCIS has to be surgically eradicated.

157

So there needs to be a resection with a negative margin.

158

And generally speaking, for a pathologist, a negative margin means it's not at ink.

159

But for DCIS, it needs to be beyond 2 millimeters.

160

So this completes cases 3 and 4.

下載應用

流利口語所需的一切

AI 發音評分逐句打分

音標練習掌握每個音

詞彙學習建立你的詞庫

詞彙遊戲邊玩邊學

掃碼

Download on theApp Store Get it onGoogle Play

同頻道

Breast Pathology Cases 5 through 7

University StudentsWorking Adults

Breast Pathology Case 2

University StudentsWorking Adults

FOR YOU

為什麼要通過這個影片練習口語？

在觀看和學習這段關於乳腺病理的解說中，您不僅能夠獲得專業的醫學知識，更能夠提高您的英語口語能力。通過模仿這些專業術語和表達方式，您可以增強您的詞彙量，讓您在醫學領域的交流中更加自信。利用這種 英語口語練習 的機會，您將能有效地掌握 shadow speech 技術，即通過重複和影子跟讀的方式，提升您的英語流利度和自然度。

語法與表達的語境分析

“We have multiple duct profiles that are being filled in by epithelial cells.” — 這句話使用了被動語態，強調了細胞的作用而非執行者，適合在醫學報告中使用。
“Here we have, for the most part, most of these are complete duct involvement.” — 該句通過使用“most of”和“for the most part”展示了對資料的適度總結，適合進行分析時的修飾。
“It is clear from low power that for most people who are experienced what this is going to be.” — 這裡使用了“it is clear”作為引入觀點，使介紹更加正式。同時加強了警示，提醒讀者需要熟悉的知識背景。

常見的發音陷阱

在這個影片中，有幾個術語可能會讓英語學習者感到困惑。例如，“epithelial”（上皮細胞）和“proliferation”（增生）的發音，對於初學者而言，常常易錯。您可能會注意到這兩個詞的重音位置不同，需要特別關注。此外，影片中的一些專業術語如“ductal carcinoma in situ”可以利用 提高英語發音 的方式，通過反覆模仿和跟讀來掌握。

練習這些發音不僅有助於您在醫學領域的溝通，還能增強您在 shadowspeak 技術中的自信，使您在與他人交流時更加流利自然。通過這樣的方式，您將在英語口語的學習上取得顯著進步。

影片中的語法

說話人最常用的結構，並附上影片中的原話：

結構	影片中的用法
被動語態 be + 過去分詞 — 強調發生了什麼，而不是誰做的	are involved · are enlarged · is referred
定語從句 who / which + 從句 — 補充說明人或事物	pseudoinclusions, which is · four, which is · people who are
現在完成時 have/has + 過去分詞 — 過去發生但與現在仍有關聯的事	have evacuated · haven't shown · has rounded

什麼是跟讀法？

跟讀法 (Shadowing) 是一種有科學依據的語言學習技巧，最初開發用於專業口譯員的培訓，並由多語言者Alexander Arguelles博士普及。這個方法簡單而強大：您在聽英語母語原聲的同時立即大聲重複——就像是一個延遲1-2秒緊跟說話者的影子。與被動聽力或語法練習不同，跟讀法強迫您的大腦和口腔肌肉同時處理並模模擬實的講話模式。研究表明它能顯著提高發音準確性，語調，節奏，連讀，聽力理解和口語流利度——使其成為雅思口語備考和真實英語交流最有效的方法之一。

影子跟讀法: 閱讀完整分步指南 →

跟讀練習: Breast Pathology Cases 3 and 4 - 通過影片學習英語口語

選擇練習模式

下載應用

同頻道

Breast Pathology Cases 5 through 7

Breast Pathology Case 2

推薦影片

Spay/Neuter Patient Care: Patient Prep - Feline

Free CCNA | VLANs (Part 2) | Day 17 | CCNA 200-301 Complete Course

How To: Ultrasound for Pneumothorax Case Study Video

Sequential, Multiple Assignment, Randomized Trial Designs With Dr Kidwell

Accurately Diagnosing the Soft Tissue Sarcoma

Analyzing Statements of Cash Flows 1 (2025 CFA® Level I Exam – FSA – Learning Module 4)

Introduction to focused ion beam scanning electron microscopy (FIB-SEM)

Intracranial Angioplasty | Dr. Sukalyan Purkayastha | Brain Mechanic

2025 Pathology Review: Practical Updates in Breast, Gastrointestinal and Genitourinary Pathology

Ambr®️ 250 High Throughput Perfusion Product Tutorial - Learn with Sartorius

為什麼要通過這個影片練習口語？

語法與表達的語境分析

常見的發音陷阱

影片中的語法

什麼是跟讀法？